Reduced contribution of endothelin to the regulation of systemic and pulmonary vascular tone in severe familial hypercholesterolaemia

Journal of Physiology

Volumn 592, Issue 8, 2014, Pages 1757-1769

  Bender, Shawn B ^a,b,c   De Beer, Vincent J ^d   Tharp, Darla L ^b   Van Deel, Elza D ^d   Bowles, Douglas K ^b   Duncker, Dirk J ^d   Laughlin, M Harold ^b   Merkus, Daphne ^d  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF MISSOURI   (United States)

^c University of Missouri   (United States)

^d ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; ENDOTHELIN 1; ENDOTHELIN RECEPTOR; TEZOSENTAN; ENDOTHELIN; ENDOTHELIN RECEPTOR ANTAGONIST; PYRIDINE DERIVATIVE; TETRAZOLE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIOLE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG EFFECT; EXERCISE; FAMILIAL HYPERCHOLESTEROLEMIA; IN VITRO STUDY; IN VIVO STUDY; LUNG VASCULAR RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; REST; SKELETAL MUSCLE; SWINE; SYSTEMIC VASCULAR RESISTANCE; VASODILATATION; ANIMAL; BLOOD; GENETICS; HYPERCHOLESTEROLEMIA; LUNG; METABOLISM; MINIPIG; PATHOPHYSIOLOGY; PHYSIOLOGY; VASCULARIZATION;

ANIMALS; ARTERIOLES; ENDOTHELIN RECEPTOR ANTAGONISTS; ENDOTHELINS; HYPERCHOLESTEROLEMIA; LUNG; MUSCLE, SKELETAL; PHYSICAL EXERTION; PYRIDINES; RECEPTORS, ENDOTHELIN; SWINE; SWINE, MINIATURE; TETRAZOLES; VASODILATION;

EID: 84898543991     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2013.267351     Document Type: Article

References (50)

1. Albertini M & Clement MG (1998). Hypoxic pulmonary vasoconstriction in pigs: role of endothelin-1, prostanoids and ATP-dependent potassium channels. Prostaglandins Leukot Essent Fatty Acids 59, 137-142.
2. 1 receptors to the control of coronary blood flow. J Appl Physiol 111, 1744-1750.
3. 1-adrenoceptor-mediated vasoconstriction in Type 2 diabetes. Am J Physiol Heart Circ Physiol 293, H2281-H2288.
4. Bender SB, Newcomer SC & Laughlin MH (2011b). Differential vulnerability of skeletal muscle feed arteries to dysfunction in insulin resistance: impact of fiber type and daily activity. Am J Physiol Heart Circ Physiol 300, H1434-H1441.
5. Bender SB, Tune JD, Borbouse L, Long X, Sturek M & Laughlin MH (2009). Altered mechanism of adenosine-induced coronary arteriolar dilation in early-stage metabolic syndrome. Exp Biol Med (Maywood) 234, 683-692.
6. Bender SB, van Houwelingen MJ, Merkus D, Duncker DJ & Laughlin MH (2010). Quantitative analysis of exercise-induced enhancement of early and late systolic retrograde coronary blood flow. J Appl Physiol 108, 507-514.
7. Brasileiro-Santos MS, Barreto-Filho JAS, Santos RD, Chacra APM, Sangaleti CT, Alvez G, Bezerra OC, Bortoloto LA, Irigoyen MC & Consolim-Colombo FM (2013). Statin restores cardiac autonomic response to acute hypoxia in hypercholesterolaemia. Eur J Clin Invest 43, 1291-1298.
8. Cardillo C, Kilcoyne CM, Cannon RO III & Panza JA (2000). Increased activity of endogenous endothelin in patients with hypercholesterolemia. J Am Coll Cardiol 36, 1483-1488.
9. Checovich WJ, Fitch WL, Krauss RM, Smith MP, Rapacz J, Smith CL & Attie AD (1988). Defective catabolism and abnormal composition of low-density lipoproteins from mutant pigs with hypercholesterolemia. Biochemistry (Mosc) 27, 1934-1941.
10. de Beer VJ, Merkus D, Bender SB, Tharp DL, Bowles DK, Duncker DJ & Laughlin MH (2013). Familial hypercholesterolemia impairs exercise-induced vasodilation due to reduced NO bioavailability. J Appl Physiol 115, 1767-1776.
11. Duncker DJ, Haitsma DB, Liem DA, Verdouw PD & Merkus D (2005). Exercise unmasks autonomic dysfunction in swine with a recent myocardial infarction. Cardiovasc Res 65, 889-896.
12. 2-consumption in exercising swine. Cardiovasc Res 47, 738-748.
13. Duncker DJ, Stubenitsky R & Verdouw PD (1998). Role of adenosine in the regulation of coronary blood flow in swine at rest and during treadmill exercise. Am J Physiol Heart Circ Physiol 275, H1663-H1672.
14. Fleisch M, Sutsch G, Yan XW, Wenzel RR, Binggeli C, Bianchetti MG, Meier B, Kiowski W & Luscher TF (2000). Systemic, pulmonary, and renal hemodynamic effects of endothelin ET(A/B)-receptor blockade in patients with maintained left ventricular function. J Cardiovasc Pharmacol 36, 302-309.
15. Goligorsky MS, Tsukahara H, Magazine H, Andersen TT, Malik AB & Bahou WF (1994). Termination of endothelin signaling: role of nitric oxide. J Cell Physiol 158, 485-494.
16. Haynes WG, Ferro CJ, O'Kane KP, Somerville D, Lomax CC & Webb DJ (1996). Systemic endothelin receptor blockade decreases peripheral vascular resistance and blood pressure in humans. Circulation 93, 1860-1870.
17. Holm P & Franco-Cereceda A (1999). Haemodynamic influence and endothelin-1 plasma concentrations by selective or non-selective endothelin receptor antagonists in the pig in vivo. Acta Physiol Scand 165, 163-168.
18. Houweling B, Merkus D, Dekker MM & Duncker DJ (2005). Nitric oxide blunts the endothelin-mediated pulmonary vasoconstriction in exercising swine. J Physiol 568, 629-638.
19. Johnson W, Nohria A, Garrett L, Fang JC, Igo J, Katai M, Ganz P & Creager MA (2002). Contribution of endothelin to pulmonary vascular tone under normoxic and hypoxic conditions. Am J Physiol Heart Circ Physiol 283, H568-H575.
20. Kelly LK, Wedgwood S, Steinhorn RH & Black SM (2004). Nitric oxide decreases endothelin-1 secretion through the activation of soluble guanylate cyclase. Am J Physiol Lung Cell Mol Physiol 286, L984-L991.
21. Lambert E, Straznicky N, Sari CI, Eikelis N, Hering D, Head G, Dixon J, Esler M, Schlaich M & Lambert G (2013). Dyslipidemia is associated with sympathetic nervous activation and impaired endothelial function in young females. Am J Hypertens 26, 250-256.
22. Laughlin MH, Davis MJ, Secher NH, van Lieshout JJ, Arce-Esquivel AA, Simmons GH, Bender SB, Padilla J, Bache RJ, Merkus D & Duncker DJ (2012). Peripheral circulation. Compr Physiol 2, 321-447.
23. Laughlin MH, Newcomer SC & Bender SB (2008). Importance of hemodynamic forces as signals for exercise-induced changes in endothelial cell phenotype. J Appl Physiol 104, 588-600.
24. Lerman A, Webster MW, Chesebro JH, Edwards WD, Wei CM, Fuster V & Burnett JC Jr (1993). Circulating and tissue endothelin immunoreactivity in hypercholesterolemic pigs. Circulation 88, 2923-2928.
25. Libby P, Ridker PM & Hansson GK (2011). Progress and challenges in translating the biology of atherosclerosis. Nature 473, 317-325.
26. Liyanage KE, Burnett JR, Hooper AJ & van Bockxmeer FM (2011). Familial hypercholesterolemia: epidemiology, Neolithic origins and modern geographic distribution. Crit Rev Clin Lab Sci 48, 1-18.
27. Lowe SW, Checovich WJ, Rapacz J & Attie AD (1988). Defective receptor binding of low density lipoprotein from pigs possessing mutant apolipoprotein B alleles. J Biol Chem 263, 15467-15473.
28. McEniery CM, Wilkinson IB, Jenkins DG & Webb DJ (2002). Endogenous endothelin-1 limits exercise-induced vasodilation in hypertensive humans. Hypertension 40, 202-206.
29. Maeda S, Miyauchi T, Iemitsu M, Tanabe T, Irukayama-Tomobe Y, Goto K, Yamaguchi I & Matsuda M (2002). Involvement of endogenous endothelin-1 in exercise-induced redistribution of tissue blood flow: an endothelin receptor antagonist reduces the redistribution. Circulation 106, 2188-2193.
30. Maeda S, Miyauchi T, Sakane M, Saito M, Maki S, Goto K & Matsuda M (1997). Does endothelin-1 participate in the exercise-induced changes of blood flow distribution of muscles in humans? J Appl Physiol 82, 1107-1111.
31. Mather KJ, Lteif A, Steinberg HO & Baron AD (2004). Interactions between endothelin and nitric oxide in the regulation of vascular tone in obesity and diabetes. Diabetes 53, 2060-2066.
32. Mather KJ, Mirzamohammadi B, Lteif A, Steinberg HO & Baron AD (2002). Endothelin contributes to basal coronary tone and endothelial dysfunction in human obesity and type 2 diabetes. Diabetes 51 3517-3523.
33. Mathew V, Cannan CR, Miller VM, Barber DA, Hasdai D, Schwartz RS, Holmes DR Jr & Lerman A (1997). Enhanced endothelin-mediated coronary vasoconstriction and attenuated basal nitric oxide activity in experimental hypercholesterolemia. Circulation 96, 1930-1936.
34. Maxwell AJ, Niebauer J, Lin PS, Tsao PS, Bernstein D & Cooke JP (2009). Hypercholesterolemia impairs exercise capacity in mice. Vasc Med 14, 249-257.
35. Merkus D, Houweling B, Mirza A, Boomsma F, Van Den Meiracker AH & Duncker DJ (2003). Contribution of endothelin and its receptors to the regulation of vascular tone during exercise is different in the systemic, coronary and pulmonary circulation. Cardiovasc Res 59, 745-754.
36. Merkus D, Sorop O, Houweling B, Boomsma F, Van Den Meiracker AH & Duncker DJ (2006). NO and prostanoids blunt endothelin-mediated coronary vasoconstrictor influence in exercising swine. Am J Physiol Heart Circ Physiol 291, H2075-H2081.
37. Niebauer J, Maxwell AJ, Lin PS, Tsao PS, Kosek J, Bernstein D & Cooke JP (1999). Impaired aerobic capacity in hypercholesterolemic mice: partial reversal by exercise training. Am J Physiol Heart Circ Physiol 276, H1346-H1354.
38. Paris D, Town T, Humphrey J, Yokota K & Mullan M (2000). Cholesterol modulates vascular reactivity to endothelin-1 by stimulating a pro-inflammatory pathway. Biochem Biophys Res Commun 274, 553-558.
39. Phivthong-ngam L, Bode-Böger SM, Böger RH, Böhme M, Brandes RP, Mügge A & Frölich JC (1998). Dietary L-arginine normalizes endothelin-induced vascular contractions in cholesterol-fed rabbits. J Cardiovasc Pharmacol 32, 300-307.
40. Pitsavos CH, Chrysohoou C, Panagiotakos DB, Kokkinos P, Skoumas J, Papaioannou I, Michaelides AP, Singh S & Stefanadis CI (2004). Exercise capacity and heart rate recovery as predictors of coronary heart disease events, in patients with heterozygous Familial Hypercholesterolemia. Atherosclerosis 173, 345-350.
41. Prescott MF, McBride CH, Hasler-Rapacz J, Von Linden J & Rapacz J (1991). Development of complex atherosclerotic lesions in pigs with inherited hyper-LDL cholesterolemia bearing mutant alleles for apolipoprotein B. Am J Pathol 139, 139-147.
42. Rapacz J, Hasler-Rapacz J, Taylor KM, Checovich WJ & Attie AD (1986). Lipoprotein mutations in pigs are associated with elevated plasma cholesterol and atherosclerosis. Science 234, 1573-1577.
43. Rask-Madsen C & King GL (2007). Mechanisms of Disease: endothelial dysfunction in insulin resistance and diabetes. Nat Clin Pract Endocrinol Metab 3, 46-56.
44. Ruschitzka F, Moehrlen U, Quaschning T, Lachat M, Noll G, Shaw S, Yang Z, Teupser D, Subkowski T, Turina MI & Lüscher TF (2000). Tissue endothelin-converting enzyme activity correlates with cardiovascular risk factors in coronary artery disease. Circulation 102, 1086-1092.
45. Smith CC, Prichard BN & Betteridge DJ (1992). Plasma and platelet free catecholamine concentrations in patients with familial hypercholesterolaemia. Clin Sci (Lond) 82, 113-116.
46. 2 delivery and utilization in swine during treadmill exercise. Cardiovasc Res 39, 459-474.
47. Taner CB, Severson SR, Best PJM, Lerman A & Miller VM (2001). Treatment with endothelin-receptor antagonists increases NOS activity in hypercholesterolemia. J Appl Physiol 90, 816-820.
48. Tschakovsky ME & Joyner MJ (2008). Nitric oxide and muscle blood flow in exercise. Appl Physiol Nutr Metab 33, 151-160.
49. van Essen GJ, Vernooij JCM, Heesterbeek JAP, Anjema D, Merkus D & Duncker DJ (2009). Does cardiovascular performance of modern fattening pigs obey allometric scaling laws? J Anim Sci 87, 1991-1997.
50. Wagner OF, Christ G, Wojta J, Vierhapper H, Parzer S, Nowotny PJ, Schneider B, Waldhausl W & Binder BR (1992). Polar secretion of endothelin-1 by cultured endothelial cells. J Biol Chem 267, 16066-16068.